Effect of GLP1 Receptor Agonist on Brain Insulin Responsiveness
ClinicalTrials.gov · NCT06487832 · Registry updated: 2025-03-30
- Condition / research focus
- Normal Weight; Overweight and Obesity; Insulin Sensitivity; Insulin Resistance
- Sponsor
- University Hospital Tuebingen
- Countries with listed sites
- Germany
- Registry dates and results
- Start: 2024-07-01. Completion: 2027-12-31 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- Subcutaneous GLP1-RA (other)
- Subcutaneous placebo (other)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- University Clinic Tubingen, Department of Internal Medicine IV
Tübingen, Germany